The Resident Doctors Association of AIIMS on Friday termed the government decision ending the need to quarantine healthcare workers after COVID-19 duty a "non-scientific approach", saying it will prove detrimental for the workers, the patients and the effort to contain the pandemic.
In a letter to the AIIMS Director, the RDA said if availability of healthcare workers (HCWs) to run hospital services is a problem then there should be provision to test them on the day 5-7 before they return to work to ensure workplace transmission doesn't occur.
Shortening the quarantine duration and denying mandatory testing on day 5-7 post-duty will turn to a deadly combination which will derail the battle against pandemic, the RDA said.
"We would like to bring to your kind notice the government's ill-founded and non-scientific approach to revise already existing protocol of two-week COVID duty followed by a two-week quarantine, will prove to be detrimental for the HCWS, patients and the country's effort to contain the pandemic," the letter signed by RDA President Adarsh Pratap Singh and General Secretary Srinivas Rajkumar T read.
As per the Union Health Ministry guidelines issued on May 15, healthcare workers serving in COVID-19 areas do not need to undergo quarantine unless there has been violation in the use of PPE or any other form of high-risk exposure or they have symptoms suggestive of coronavirus infection.
Previously, all healthcare personnel doing COVID-19 duty had to work for 14 days and it was then followed by a two-week quarantine to ensure that they did not spread the infection to anyone else.
"Shortening the quarantine duration and denying mandatory testing on day 5-7 post-duty will turn to a deadly combination which will derail the battle against pandemic.
"This is an act of government forsaking the people of the country and their saviors the underpaid, overworked doctor with minimal safety precautions in most parts of the country during pandemic as cases approaches its peak," they said.
"We as healthcare workers are accepting the increased risk of acquiring the infection but not inadvertently transmitting the infection to people who come in contact with us for treatment or otherwise."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
